683 Capital Management’s Phathom Pharmaceuticals PHAT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$20.6M	Buy	1,850,000 +65,000	+4%	+$821K	1.91%	21
2025 Q4	$29.6M	Sell	1,785,000 -35,380	-2%	-$505K	2.46%	17
2025 Q3	$21.4M	Sell	1,820,380 -284,620	-14%	-$2.94M	1.95%	25
2025 Q2	$20.2M	Buy	2,105,000 +660,000	+46%	+$3.65M	2.05%	18
2025 Q1	$9.06M	Buy	1,445,000 +420,000	+41%	+$2.55M	0.92%	47
2024 Q4	$8.32M	Buy	1,025,000 +15,000	+1%	+$186K	0.82%	50
2024 Q3	$18.3M	Sell	1,010,000 -390,000	-28%	-$5.45M	1.86%	22
2024 Q2	$14.4M	Sell	1,400,000 -250,000	-15%	-$2.57M	1.51%	28
2024 Q1	$17.5M	Buy	1,650,000 +370,000	+29%	+$3.14M	1.79%	26
2023 Q4	$11.7M	Buy	1,280,000 +180,000	+16%	+$1.55M	1.17%	40
2023 Q3	$11.4M	Sell	1,100,000 -187,500	-15%	-$2.57M	1.16%	37
2023 Q2	$18.4M	Sell	1,287,500 -38,000	-3%	-$438K	1.79%	22
2023 Q1	$9.46M	Sell	1,325,500 -24,500	-2%	-$215K	0.85%	41
2022 Q4	$15.1M	Sell	1,350,000 -313,943	-19%	-$3.24M	1.37%	21
2022 Q3	$18.4M	Buy	1,663,943 +223,943	+16%	+$2.13M	1.49%	23
2022 Q2	$12.2M	Buy	1,440,000 +1,085,000	+306%	+$11.2M	0.88%	36
2022 Q1	$4.83M	Buy	355,000 +64,405	+22%	+$1.04M	0.29%	82
2021 Q4	$5.72M	Buy	+290,595	New	+$6.84M	0.27%	85